Caxton Associates (New York)’s Sabra Healthcare REIT SBRA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-152,775
| Closed | -$2.84M | – | 650 |
|
2024
Q3 | $2.84M | Sell |
152,775
-31,819
| -17% | -$592K | 0.11% | 70 |
|
2024
Q2 | $2.84M | Buy |
+184,594
| New | +$2.84M | 0.1% | 110 |
|
2023
Q2 | – | Sell |
-11,531
| Closed | -$133K | – | 632 |
|
2023
Q1 | $133K | Hold |
11,531
| – | – | 0.02% | 445 |
|
2022
Q4 | $143K | Buy |
+11,531
| New | +$143K | 0.01% | 385 |
|
2022
Q3 | – | Sell |
-23,439
| Closed | -$327K | – | 629 |
|
2022
Q2 | $327K | Sell |
23,439
-32,534
| -58% | -$454K | 0.03% | 342 |
|
2022
Q1 | $833K | Buy |
55,973
+18,300
| +49% | +$272K | 0.07% | 120 |
|
2021
Q4 | $510K | Buy |
+37,673
| New | +$510K | 0.05% | 249 |
|
2021
Q3 | – | Sell |
-22,535
| Closed | -$410K | – | 558 |
|
2021
Q2 | $410K | Sell |
22,535
-13,196
| -37% | -$240K | 0.05% | 208 |
|
2021
Q1 | $620K | Buy |
+35,731
| New | +$620K | 0.06% | 106 |
|
2020
Q2 | – | Sell |
-48,347
| Closed | -$528K | – | 583 |
|
2020
Q1 | $528K | Buy |
+48,347
| New | +$528K | 0.1% | 148 |
|